Targeting Tumors Using Estrogen Receptor Ligand Conjugates

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|3|370-380

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.3, 2009-05, pp. : 370-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design, Synthesis and Biochemical Evaluation of Estrogen Receptor Ligand Conjugates as Tumour Targeting Agents

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 3, 2012-03 ,pp. : 295-304

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Docking Optimization and Analysis of Protein-Ligand Interactions of Estrogen Receptor Alpha using AMMOS Software

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-03 ,pp. : 83-94

Bentham Science Publishers

Access to resources Recommend Favorite

Novel star HPMA-based polymer conjugates for passive targeting to solid tumors

By Etrych T.   Strohalm J.   Chytil P.   ŘŘíhová B.   Ulbrich K.  

Journal of Drug Targeting, Vol. 19, Iss. 10, 2011-12 ,pp. : 874-889

Informa Healthcare

Access to resources Recommend Favorite

Metallodrug Conjugates with Steroids and Selective Estrogen Receptor Modulators (SERM)

By  

Current Medicinal Chemistry, Vol. 16, Iss. 18, 2009-06 ,pp. : 2324-2337

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Targeting of Liposomes to Macrophages Using a Ligand with High Affinity for the Macrophage Scavenger Receptor Class A

By  

Current Drug Discovery Technologies, Vol. 3, Iss. 2, 2006-06 ,pp. : 135-144

Bentham Science Publishers

Access to resources Recommend Favorite